Related by context. All words. (Click for frequent words.) 77 CBLB# 73 NEUMUNE 71 Protexia R 68 Valortim 68 Protexia ® 68 Acute Radiation Syndrome ARS 67 Anthim 67 AEOL # 67 Valortim ® 67 SparVax TM 66 rBChE 66 Homspera 66 preclinical efficacy 65 Valortim R 65 PhG alpha 1 65 CEQ# 65 Protexia 65 MGd 64 Radilex 64 NP2 Enkephalin 64 bafetinib 64 SparVax ™ 63 immune modulatory 63 RiVax ™ 63 eniluracil 63 PEG SN# 63 CGEN # 63 DXL# 63 DermaVir 63 depsipeptide 63 indibulin 63 AVP #D# 63 mertansine 63 RiVax TM 63 Azedra 63 Cleveland BioLabs 63 RiVax 62 YONDELIS 62 #ME# 62 ANAVEX #-# [001] 62 MAXY G# 62 Tß4 62 Archexin 62 compound Protectan CBLB# 62 anti CD3 antibody 62 immunotoxins 62 Protectan 62 immune modulator 62 HQK 62 Phase #b/#a clinical 62 Ebola SNALP 62 EndoTAG TM -1 62 OxBC 62 Traficet EN 62 ganetespib 62 PSMA ADC 62 OncoVEX 62 OncoVEX GM CSF 62 demonstrated antitumor activity 62 ATL# [002] 61 R#/MEM # 61 nanoviricides 61 Onconase 61 Tarvacin TM 61 TKM Ebola 61 IRX 2 61 oral antiviral 61 Tβ4 61 CDDO Im 61 NEUGENE 61 ATL# [001] 61 antigen sparing 61 NPC 1C 61 ENMD # 61 OHR/AVR# 61 Curaxin 61 torezolid phosphate 61 Aplidin 61 potent cytotoxic 61 TRO# 61 AP# [003] 61 CA4P 61 Restanza 61 cartilage regeneration 61 radiation countermeasure 61 anti CD# antibodies 61 preclinical toxicology 61 sulodexide 60 iSONEP 60 masitinib 60 H#N# VLP vaccine 60 Nanobody ® 60 Carfilzomib 60 Bezielle 60 ON #.Na 60 TLR antagonists 60 rPA anthrax vaccine 60 Interferon alpha 60 antitumoral 60 intradermal injection 60 favorable pharmacokinetic profile 60 trabectedin 60 DCVax ® 60 trastuzumab DM1 T DM1 60 Curaxin CBLC# 60 proteasome inhibitor 60 histone deacetylase inhibitor 60 Lenocta 60 daptomycin 60 Factor VIIa 60 HDL Selective Delipidation 60 immune modulating 60 PCK# 60 PDE4 inhibitor 60 JAK inhibitors 60 Lpathomab 60 tezampanel NGX# 60 Neumune 60 PEGylated interferon 60 Panzem 60 GMX# 60 Reolysin 60 CBLC# 60 GLP toxicology studies 60 immune modulation 60 IMP# 60 Chemophase 60 Trofex 60 CIMZIA TM 60 Zalypsis 60 dexanabinol 60 GLPG# 60 rxRNA 60 therapeutic monoclonal antibody 60 Golimumab 60 carcinogenicity study 60 Sym# 60 immunomodulatory 60 teplizumab 60 GeoVax vaccine 60 vivo efficacy 60 pharmacokinetic PK study 60 butyrylcholinesterase 60 Symadex 60 fosbretabulin 60 cidofovir 60 targeted radiotherapeutic 60 Cethrin R 60 huC# DM4 59 JAK3 59 AEG# 59 milatuzumab 59 anti CD# antibody 59 GRN# 59 Xanafide 59 PROCHYMAL 59 Alocrest 59 immunotherapeutic vaccine 59 pharmacodynamic markers 59 therapeutic monoclonal antibodies 59 Guanilib 59 cytotoxic effects 59 vascular disrupting agents 59 cytoprotective 59 oral prodrug 59 nicotinic alpha 7 59 Prodarsan ® 59 OXi# 59 Panzem R 59 nanoviricide drug 59 Exherin TM 59 Medical Countermeasure 59 TELINTRA 59 Phase Ib study 59 forodesine 59 delipidation 59 XOMA 3AB 59 cleavable linker 59 PXD# 59 DermaVir Patch 59 lomitapide 59 recombinant subunit vaccine 59 cMET 59 ELACYT 59 Tamibarotene 59 liposomal formulation 59 Development Authority BARDA 59 FluCide 59 MEK inhibitor 59 IMA# 59 Nanobody 59 immunomodulatory properties 59 Valortim TM 59 Phase IIb clinical trials 59 Chemokine 59 ISTODAX 59 synthetic retinoid 59 rPA 59 TLR9 agonist 59 MGN# 59 intranasal delivery 59 HCD# [002] 59 Aviptadil 59 Cethromycin 59 SNT MC# 59 Squalamine 59 immunomodulator 59 DispersinB ® 59 rilonacept 59 adenoviral vectors 59 immunoregulation 59 Neuradiab 59 selective inhibition 59 EV# vaccine 59 Virulizin ® 59 EP #R 59 preclinically 59 Bendavia 59 Perifosine 59 BiTE antibody 59 GRNVAC1 59 targeting CD# 58 CMV vaccine 58 RhuDex ® 58 HCV protease inhibitors 58 Fibrillex TM 58 Aflibercept 58 investigational monoclonal antibody 58 Androxal TM 58 SAR# [004] 58 Phase IIB 58 Multimeric 58 delafloxacin 58 chemotherapy induced neutropenia 58 CD# monoclonal antibody 58 methylnaltrexone 58 menadione 58 Omacetaxine 58 Allovectin 7 58 Anavex #-# 58 JAK inhibitor 58 immune stimulatory 58 vivo validation 58 radiolabeled TM# 58 MVA BN R 58 adenovector 58 anti CD3 58 UPLYSO 58 EGS# 58 tanespimycin 58 Panzem R NCD 58 Altastaph 58 XmAb# 58 alkylating agent 58 Mucosal 58 lucinactant 58 Fx #A 58 multiple myeloma MM 58 Tarvacin 58 bioscavenger 58 pomalidomide 58 nitazoxanide 58 Triapine R 58 OMP #M# 58 IAP inhibitor 58 vivo potency 58 TB4 58 ara C 58 busulfan 58 Vaxfectin TM 58 Cardio Vascu Grow 58 Civacir 58 MIS# 58 cannabinor 58 ONCONASE R 58 TG# [003] 58 HuMax EGFr 58 antitumor 58 radiotherapeutic 58 kidney urologic 58 immunotherapeutic 58 DepoVax TM 58 dacetuzumab 58 Allovectin 7 R 58 Dr. Fonstein 58 vinca alkaloid 58 PEGylated 58 CD# antibody [001] 58 cilengitide 58 ixabepilone 58 CG# [003] 58 pharmacodynamic PD 58 RNAi Therapeutic 58 TÎ ² 4 58 rFVIII 58 PDX pralatrexate 58 GRNOPC1 58 lenalidomide Revlimid R 58 PHX# 58 solithromycin 58 mda 7 58 AFRRI 58 DAS# [001] 58 anticancer therapeutics 58 NEUGENE antisense 58 CLORETAZINE TM VNP#M 58 Thiovir 58 DispersinB R 58 mitogen activated ERK kinase 58 MGCD# [001] 58 Vaxfectin 58 RIGScan CR 58 Dapagliflozin 58 JAK2 inhibitor 58 RDEA# 58 nonclinical studies 58 Triolex 58 GRN#L 58 drug ISA# 58 OvaRex ® MAb 58 NexACT 57 humanized antibodies 57 AKT inhibitor 57 Excellarate 57 Cethrin 57 riociguat 57 TACI Ig 57 Hemopurifier 57 NV1FGF 57 STAT3 signaling 57 Vascugel R 57 novel anticancer 57 Cloretazine R VNP#M 57 Universal Flu Vaccine 57 imetelstat 57 INCB# [001] 57 nanoviricide 57 IMVAMUNE TM 57 defensin mimetic antibiotic 57 midstage clinical 57 GVAX ® 57 romidepsin novel 57 biodefense countermeasure 57 HCV antiviral 57 CCX# 57 Neugene 57 ATL/TV# 57 Zysolin TM 57 HCV protease inhibitor 57 anticancer agent 57 Cerashield 57 PLX cells 57 SynCon 57 CINTREDEKIN BESUDOTOX 57 Blinatumomab 57 postexposure 57 Pralatrexate 57 PLK1 SNALP 57 Homspera TM 57 HspE7 57 deforolimus 57 ELND# 57 Proellex TM 57 REP# 57 orally dosed 57 Prochymal 57 NXL# 57 mTOR inhibition 57 OMP #R# 57 Revimmune 57 attenuated strain 57 immunological diseases 57 SCH # 57 cellular immunotherapy 57 HGS# 57 ASONEP 57 investigational humanized monoclonal antibody 57 antibody MAb 57 Toraymyxin TM 57 TREANDA 57 ROTARIX 57 Spiegelmer ® 57 cytostatic 57 APOPTONE 57 ACZ# 57 oritavancin 57 axitinib 57 radezolid 57 vosaroxin 57 TKM ApoB 57 MAGE A3 ASCI 57 TRIOLEX 57 GeoVax AIDS vaccine 57 Fast Track Status 57 Radezolid 57 acyclovir Lauriad R 57 atacicept 57 Maxy G# 57 Phase Ib II 57 ALN TTR 57 Anidulafungin 57 CORT # 57 MEK inhibitor RDEA# 57 Litx 57 Alferon N 57 TransVax TM 57 Urocidin 57 Cloretazine ® 57 EOquin TM 57 GAP #B# 57 NEUGENE R 57 IND submission 57 Sudhir Agrawal D.Phil 57 histamine dihydrochloride 57 antisense inhibitor 57 Nanobodies ® 57 OvaRex R 57 pharmacokinetic studies 57 Tarceva TM 57 Maribavir 57 oncolytic virus therapy 57 Dacogen injection 57 obatoclax 57 Prodarsan R 57 GelSite polymer 57 monoclonal antibody mAb 57 Arikace 57 FOLFOX chemotherapy 57 mTOR inhibitors 57 eTag assays 57 Hsp# Inhibitor 57 Lisofylline LSF 57 targeted antifolate 57 HGS ETR2 57 biotherapy 57 Lixivaptan 57 immunotherapeutic agent 57 systemically administered 57 Apoptone 57 PI3K/Akt pathway inhibitor 57 hGH CTP 57 thorough QT 57 bortezomib Velcade 57 ALN TTR# 57 GGF2 57 anticancer therapy 57 Amplimexon 57 bevacizumab Avastin ® 57 Aganocide 57 AzaSite Plus 57 tetravalent vaccine 57 BRAF inhibitors 57 MEK inhibitors 57 TransVax ™ 57 Proxinium TM 57 AQ4N 57 Chrysalin 57 oncolytic viruses 57 oral methylnaltrexone 57 Intarcia 57 triphendiol 57 HSP# inhibitor 57 developing TB4 57 G#DT 57 Ramoplanin 57 Allovectin 7 ® 57 sodium thiosulfate STS 57 ganaxolone 57 TKM PLK1 57 Phase #b/#a 57 veltuzumab 57 preclinical 57 pDNA vaccines 57 Solazed 57 thymosin beta 4 57 acadesine 57 RAV# 57 enzastaurin 57 Neulasta ® 57 DAVANAT 57 ELND-#/AZD-# 57 voreloxin 57 tesetaxel 57 orally administered inhibitor 56 preclinical pharmacokinetic 56 mapatumumab 56 anticancer compound 56 R#/MEM 56 Kevetrin ™ 56 plasmid DNA vaccine 56 dose cohort 56 Viprovex TM 56 Vacc 4x 56 huN# DM1 56 vemurafenib 56 trivalent influenza vaccine 56 HuMax CD4 56 recombinant interferon 56 Annexin V 56 HepaGam B 56 PRTX 56 xenograft models 56 omega interferon 56 Vidofludimus 56 Immunotherapeutic 56 gallium containing 56 tumorigenicity 56 telomerase activator 56 glufosfamide 56 immunotoxin 56 Lipid Sciences 56 CRD5 56 histone deacetylase HDAC 56 glucokinase activator 56 intratumoral injection 56 CCR1 56 Rasagiline 56 omecamtiv mecarbil 56 Telatinib 56 Behcet uveitis 56 Phase Ib clinical 56 vidofludimus 56 replicon 56 CR# vcMMAE 56 BrachySil 56 RNAi therapeutic targeting 56 docetaxel Taxotere ® 56 HDAC Inhibitor 56 YONDELIS R 56 trastuzumab Herceptin ® 56 ProMune 56 ZFP Therapeutic 56 ImQuest 56 NTDDS 56 Phase IIb III 56 IgG1 antibody 56 GLP toxicology 56 anti secretory 56 Nuron Biotech 56 MT#/MEDI-# 56 Gleevec resistant 56 Advexin 56 phase Ib 56 CYT# potent vascular disrupting 56 Diamyd ® 56 HDL Mimetic Peptide 56 Bioral 56 otelixizumab 56 CYT# 56 Kahalalide F 56 receptor tyrosine kinase inhibitor 56 telaprevir VX 56 IMC A# 56 ActivX 56 histone deacetylase HDAC inhibitor 56 prophylactic vaccine 56 CRMD# 56 bavituximab 56 PKC# 56 Twinrix 56 STEDESA 56 Vandetanib 56 Darinaparsin 56 NovaBay Aganocide compounds 56 MOZOBIL 56 adipose derived stem cells 56 Talabostat 56 Bellicum 56 ESBA# 56 Sphingomab 56 HBV vaccine 56 gastro intestinal inflammation 56 BNC# 56 iroxanadine 56 liposomal doxorubicin 56 Initiates Clinical 56 TLR9 agonists 56 EGEN 56 chimeric monoclonal antibody 56 Tesetaxel 56 mGluR2 NAM 56 humanized monoclonal antibodies 56 tubulin inhibitor 56 retapamulin 56 molecular chaperone regulation 56 nucleotide analogs 56 TELCYTA 56 BAY #-# 56 BioNumerik 56 cyclophilin inhibitors 56 A3 adenosine receptor 56 cat dander allergy 56 Pafuramidine 56 Alvesco R 56 CCR9 antagonist 56 HuCAL antibodies 56 IL# PE#QQR 56 intranasal formulation 56 CINtec R 56 PD LID 56 BiTE 56 kallikrein 56 IDX# 56 pexiganan 56 BrachySil ™ 56 DepoVax 56 Inosine 56 receptor inhibitor 56 BrachySil TM 56 Pradefovir 56 radioprotection 56 cancer immunotherapies 56 Selective Electrochemical Tumor Ablation 56 prostanoid 56 PRX# 56 pharmacodynamic properties 56 Imprime PGG 56 Xcytrin R 56 trodusquemine 56 Exelixis XL# 56 Dr. Sosne 56 anti leukemic 56 custirsen 56 SomatoKine 56 SparVax 56 PROSTVAC TM 56 Virulizin R 56 Fibrin MB 56 PEGPH# 56 Trofex TM 56 SinuNase ™ 56 RAPTIVA 56 GeneICE 56 ARIKACE 56 Restanza TM 56 ToxCast TM 56 Corgentin 56 pharmacological chaperone 56 StaphVAX R 56 PRT# 56 Amrubicin 56 telomerase inhibitor 56 rALLy clinical trial 56 phase IIa clinical 56 oncolytic virus 56 Phase 1b clinical trials 56 exon skipping 56 celgosivir 56 radionuclide therapy 56 WRAIR 56 HepeX B 56 interleukin IL -# 56 novel peptide 56 HGS ETR1 56 oncolytic 56 humanized antibody 56 Vicinium TM 56 pemetrexed Alimta 56 Chemokine Therapeutics 56 Friedreich Ataxia FRDA 56 pafuramidine 56 highly immunogenic 56 Azedra TM 56 Bortezomib 56 gamma secretase inhibitor 56 prodrugs 56 thymalfasin 56 Phase Ib clinical trials 56 ADAMTS# 56 myeloablative 56 immuno therapeutic 56 radiation sensitizer 56 TBC# 56 BioVant 56 polyclonal 56 alemtuzumab MS 56 StemEx 56 Posiphen 55 ZFP Therapeutics 55 Enzyme Replacement Therapy 55 acetonide FA 55 adeno associated viruses 55 GED aPC 55 JUVISTA R Human 55 lymphoid malignancies 55 Cloretazine R 55 ulimorelin 55 Dalbavancin 55 inhaled AAT 55 VLP vaccine 55 Myocet 55 hematological malignancies 55 CRLX# 55 DiLA2 55 IMVAMUNE ® 55 drug GAP #B# 55 tolerability pharmacokinetics 55 Azedra ™ 55 talabostat 55 alagebrium 55 midstage trials 55 Apaziquone 55 autologous cellular immunotherapy 55 Pimavanserin 55 IL# PE 55 theranostic 55 Systemic Delivery 55 Bendamustine 55 DOR# 55 CCR5 mAb 55 humanized monoclonal 55 non nucleoside HCV 55 AMPAKINE CX# 55 ICA # 55 HCV polymerase 55 Poly ICLC 55 Preclinical studies suggest 55 Gleevec imatinib mesylate 55 Eculizumab 55 ISF# 55 PDE# inhibitors 55 ibudilast 55 fibrotic disease 55 DPX Survivac 55 AeroLEF TM 55 Ebola vaccine 55 ZK EPO 55 GVAX Pancreas Vaccine 55 prophylactic vaccines 55 biothreat agents 55 recombinant polyclonal antibody 55 rifalazil 55 juvenile chondrocytes 55 Voreloxin 55 zileuton 55 Anticalins 55 novel VDA molecule 55 Zemiva TM 55 tolevamer 55 Urocidin TM 55 VitiGam 55 Ceflatonin R 55 Menerba 55 neuraminidase inhibitor 55 multicenter Phase II 55 EndoTAG TM 55 Phase 1a clinical 55 LentiVector technology 55 administered subcutaneously 55 Hollis Eden 55 genotoxicity 55 pegylated 55 immunotherapeutics 55 antiangiogenic agent 55 Angiocept 55 transgenesis 55 erythropoietic 55 NanoViricides 55 Solazed TM 55 bioartificial liver 55 MAb 55 nucleoside analogues 55 phase IIb clinical 55 Fodosine 55 ANAVEX #-# [003] 55 recombinant antibodies 55 tesmilifene 55 lipopeptide 55 VEGF receptor 55 recombinant enzyme 55 engineered RAP peptides 55 Adnectin 55 therapeutic antibody 55 uric acid lowering 55 resolvins 55 peptide antigens 55 TLR agonists 55 HuMax CD# 55 volociximab 55 Cytolin ® 55 LY# [003] 55 TRV# [001] 55 4SC AG 55 IL 1ß 55 tkRNAi 55 bispecific antibody 55 cytotoxic T lymphocyte 55 HTS assay 55 urocortin 2 55 SBIR Grant 55 isavuconazole 55 seliciclib 55 AZX# 55 transdifferentiation 55 lead Aganocide compound 55 pancreatic islet cell 55 Dasatinib 55 sodium stibogluconate 55 Vascugel 55 Degarelix 55 cGMP manufacture 55 Resten NG 55 anticoagulant reversing agent 55 Mpex 55 phosphatidylserine PS targeting 55 bispecific 55 PrevOnco ™ 55 INCB# [003] 55 interferon IFN 55 CHOP chemotherapy 55 neurotrophic 55 immunotherapy 55 velafermin 55 Exelixis compounds 55 antitumor activity 55 NPM1 55 anti CD3 monoclonal 55 Gord Froehlich President 55 Aptivus ® 55 Liprotamase 55 raxibacumab 55 Telavancin 55 Phase IIIb clinical 55 cathepsin K inhibitor 55 BLA filing 55 PNP inhibitor 55 VEGF Trap 55 DCVax 55 Preclinical studies 55 diarrhea predominant irritable 55 multi kinase inhibitor 55 SIRT1 activators 55 #beta estradiol 55 pan HDAC inhibitor 55 prostone 55 Sapacitabine 55 Natalizumab 55 reslizumab 55 Silodosin 55 antituberculosis 55 investigational hepatitis B 55 davunetide intranasal AL 55 prokinetic agent 55 osteoinductive 55 OncoVex 55 Personalized Immunotherapy 55 Alzhemed TM 55 GRASPA ® 55 direct thrombin inhibitors 55 antitumor effect 55 orally bioavailable 55 L asparaginase 55 Seliciclib 55 Ketotransdel 55 ONCASPAR 55 anti CD# monoclonal 55 Mipomersen 55 novel histone deacetylase 55 angiogenesis inhibition 55 BEZ# 55 hA# 55 BAL# [001] 55 mimetics 55 proteasome inhibitors 55 novel therapeutic antibodies 55 Onalta 55 NOD SCID mice 55 thalidomide Thalomid 55 Atiprimod 55 Japanese Encephalitis vaccine 55 Anticalin ® 55 CD# CEA 55 trastuzumab Herceptin 55 radiolabeled monoclonal antibody 55 HDACi 55 Phase 2a clinical trials 55 Genasense ® 55 SinuNase TM 55 Synavive 55 oral PTH 55 thiazolides 55 angiogenesis inhibitor 55 Neo Bladder Augment 55 GVAX R 55 preclinical studies 55 2 methoxyestradiol 55 ischemia reperfusion 55 Onalta ™ 55 SCCHN 55 BXT # 55 HDAC inhibition 55 DCCR 55 immune modulators 55 pouchitis 55 nucleotide analog 55 erlotinib Tarceva 55 humanized anti 55 Bicifadine 55 IMVAMUNE R 55 influenza VLP vaccine 55 MultiStem 55 vitro experiments 55 Trastuzumab 55 Velcade bortezomib 55 HAAH 55 nalbuphine ER 55 alefacept 55 topically administered 55 ChronVac C ® 55 Xyfid TM 55 REOLYSIN ® 55 vivo preclinical 55 alvespimycin 55 SynCon ™ DNA 55 Elvitegravir 55 QLT# 54 SNALP 54 anti infective treatments 54 selective orally bioavailable 54 liposome formulations 54 Doxil ® 54 ALN PCS 54 GSK # 54 AAG geldanamycin analog 54 neratinib 54 elacytarabine 54 amrubicin 54 NeuroVax TM 54 OMAPRO 54 AEGR 54 AMPK activators 54 tafamidis 54 mAbs 54 immatics 54 Relivar 54 rhThrombin 54 small molecule thrombopoietin 54 Urocortin 2 54 immuno modulatory 54 ddRNAi 54 DOS# 54 MAXY VII 54 FOLOTYN ® 54 CB2 selective receptor agonist 54 small molecule activators 54 #I TM# 54 CA9 SCAN 54 Nicole Onetto MD 54 leading oral taxane 54 ZFP TF 54 RECOTHROM R 54 HGS ETR1 mapatumumab 54 Soliris eculizumab 54 personalized immunotherapy 54 Peer Reviewed Medical 54 angiotensin analog 54 DiabeCell ® 54 PI3K inhibitor 54 Vaxfectin TM formulated 54 flavopiridol 54 Ceflatonin 54 Plicera 54 TNFa 54 novel peptides 54 DCVax R 54 Quinamed 54 #D#C# 54 goserelin 54 CYC# 54 QuadraSphere 54 MEK Inhibitor 54 DXL TM 54 StemEx R 54 vascular insufficiency 54 FLT3 54 Vorinostat 54 AtuRNAi 54 R roscovitine 54 adult mesenchymal stem 54 Lovaxin C 54 Enzastaurin 54 TRISENOX ® 54 elotuzumab 54 Aethlon Hemopurifier R 54 Aeolus Pharmaceuticals 54 CBLI 54 NIH NIAID 54 JAK2 inhibitors 54 adipose derived regenerative 54 HE# [002] 54 Temsirolimus 54 Cx# [002] 54 polymerase inhibitors 54 Excellagen 54 azacitidine 54 recombinant protective 54 inhalation toxicology 54 RhuDex 54 Vilazodone